High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
about
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy.STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway.A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
P2860
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
High stathmin expression is a ...... ecologic oncology group study.
@en
type
label
High stathmin expression is a ...... ecologic oncology group study.
@en
prefLabel
High stathmin expression is a ...... ecologic oncology group study.
@en
P2093
P2860
P50
P1433
P1476
High stathmin expression is a ...... necologic oncology group study
@en
P2093
Eric J Devor
Floor Backes
Gini F Fleming
Jean-Marie Stephan
Jeffrey Miecznikowski
Krishnansu S Tewari
Kristina W Thiel
Megan I Samuelson
Megan McDonald
Michael J Birrer
P2860
P304
P356
10.1016/J.YGYNO.2017.05.017
P407
P577
2017-05-19T00:00:00Z